IPPRA / Grant Monitor

2026-07-07
← Board

DoW Vision, Clinical Trial Award

HT942526VRPCTA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health Science & Technology R&D

Closes
2026-11-12 · 128 d
Award ceiling
Award floor
Program funding
$2,600,000
Expected awards
1
Cost sharing
No
Posted
2026-05-05
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Supports rapid implementation of clinical trials on service-connected eye injury and visual dysfunction for applicants whose studies align with FY26 Vision Research Program focus areas.

Funds
evaluation research
University
direct
social behavioral
minor
physical sciences
minor
engineering
minor
life biomedical
central
computational data
substantial

⚑ Clinical trial award; requires IND/IDE or equivalent submitted by application deadline when applicable, and active/safe-to-proceed documentation by March 1, 2027. · Must align with at least one FY26 VRP Focus Area. · Military health relevance and transition plan are important review considerations.

Unit fits — one characterization, each unit's own rules

IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is minor; funds evaluation research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 40 partial technical depth: substantial; funds evaluation research (capped)
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas .

Distinctive Features:

· For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details.

· Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication.

· Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health.

https://cdmrp.health.mil/pubs/press/2026/vrppreann

Apply

View on Grants.gov → CONTACT: Teresa M Parker-Reeser Grants Officer <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING